MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-10-2022
Country |
 USA |
IPO year |
2014 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
23.7 M |
Market Cap[1] |
$ 2.56 M |
EBITDA (LTM) |
$ -53.2 M |
P/E (LTM) |
- |
P/S (LTM) |
0.27 |
EPS (LTM) |
-1.92 |
Other stocks of industry "Drug manufacturers"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Canopy Growth Corporation
CGC
|
$ 1.14 | -4.62 % | $ 123 M | Nasdaq Global Select Market |  Canada |
 |
Cronos Group
CRON
|
$ 2.56 | 1.24 % | $ 1.35 B | Nasdaq Global Market | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.74 | 1.94 % | $ 66.6 M | Nasdaq Global Select Market | USA |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | USA |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Emergent BioSolutions
EBS
|
$ 11.08 | 0.82 % | $ 567 M | NYSE,SPB | USA |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
Evolus
EOLS
|
$ 5.05 | -2.88 % | $ 313 M | Nasdaq Global Market | USA |
 |
Harrow Health
HROW
|
$ 47.49 | -0.86 % | $ 1.55 B | Nasdaq Global Market | USA |
 |
China Pharma Holdings
CPHI
|
$ 1.25 | - | $ 21.8 M | NYSE American |  China |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
OrganiGram Holdings
OGI
|
$ 1.62 | 0.62 % | $ 402 M | Nasdaq Global Select Market | Canada |
 |
Bausch Health Companies
BHC
|
$ 6.75 | -3.3 % | $ 2.46 B | NYSE | Canada |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
Sundial Growers
SNDL
|
$ 1.58 | -2.17 % | $ 3.37 M | Nasdaq Global Select Market | Canada |
 |
Organogenesis Holdings
ORGO
|
$ 3.64 | -3.96 % | $ 479 M | Nasdaq Capital Market | USA |
 |
Pacira BioSciences
PCRX
|
$ 19.43 | 1.38 % | $ 899 M | Nasdaq Global Select Market,SPB | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
$ 21.51 | 0.14 % | $ 2.05 B | Nasdaq Global Select Market |  France |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Perrigo Company plc
PRGO
|
$ 15.06 | 0.2 % | $ 2.07 B | NYSE | USA |
 |
Aurora Cannabis
ACB
|
$ 4.14 | -2.13 % | $ 86.3 M | NYSE | Canada |
 |
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
Rockwell Medical
RMTI
|
$ 1.22 | 27.44 % | $ 28.5 M | Nasdaq Global Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 3.33 | 1.06 % | $ 4.13 M | Nasdaq Capital Market | USA |
 |
Relmada Therapeutics
RLMD
|
$ 3.93 | 5.01 % | $ 118 M | Nasdaq Global Select Market,SPB | USA |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Assertio Holdings
ASRT
|
$ 12.04 | 4.88 % | $ 855 M | Nasdaq Capital Market | USA |
 |
Tilray
TLRY
|
$ 8.74 | -7.62 % | $ 5.4 B | Nasdaq Global Select Market | Canada |
 |
Solid Biosciences
SLDB
|
$ 5.59 | 2.19 % | $ 228 M | Nasdaq Global Select Market,SPB | USA |
 |
SCYNEXIS
SCYX
|
$ 0.65 | -0.68 % | $ 31.1 M | Nasdaq Global Select Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
Veru
VERU
|
$ 2.53 | -5.95 % | $ 341 M | Nasdaq Capital Market | USA |
 |
TherapeuticsMD
TXMD
|
$ 2.55 | 14.39 % | $ 26.6 M | Nasdaq Global Select Market | USA |
 |
Viatris
VTRS
|
$ 12.66 | -1.59 % | $ 15.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |
 |
cbdMD
YCBD
|
$ 0.83 | -9.94 % | $ 3.58 M | NYSE American | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.